Baker Institute experts blog on opportunities for the U.S. and Mexico to jointly address the neglected tropical diseases found among the poorest people living in both countries.
Peter J. Hotez, Jennifer R. Herricks, Kirstin R.W. MatthewsSeptember 28, 2015
This journal article examines the spread of neglected tropical diseases (NTDs) in Middle East countries occupied by the Islamic State and discusses ways to treat and prevent them.
The 10 member states of the Association of Southeast Asian Nations (ASEAN) constitute an economic powerhouse, yet these countries also harbor a mostly hidden burden of poverty and neglected tropical diseases (NTDs). Almost 200 million people live in extreme poverty in ASEAN countries, and many of them are affected by at least one NTD. However, NTDs are prevalent even among upper middle-income ASEAN countries such as Malaysia and Thailand, especially among the indigenous populations.
Peter Hotez, fellow in disease and poverty, testified about the continuing threat of neglected tropical diseases before the U.S. House Committee on Foreign Affairs Subcommittee on Africa, Global Health, Global Human Rights and International Organizations.
Peter Hotez discusses his work on neglected tropical diseases and the future direction of disease elimination and science diplomacy. Published in the journal Molecular Medicine, December 2014.
A new analysis reveals substantial global health gains for AIDS, malaria and neglected tropical diseases that were first targeted by the administration of President George W. Bush in 2003 and then greatly expanded by the Obama administration. Beginning in 2016, an incoming administration will have opportunities to build on this legacy to control and eliminate poverty-related diseases — including those with pandemic potential — and to assert American leadership while being mindful of fiscal constraints.
The human papillomavirus (HPV) affects over 80 million Americans, causing more than 40,000 cases of HPV-associated cancers in the U.S. In 2006, the FDA licensed the first HPV vaccine, which could help save thousands of lives; no cure for HPV currently exists. However, the political controversy raised by the vaccine has limited its acceptance and use. Such resistance potentially jeopardizes an opportunity to reduce cancer rates in Texas and the broader United States.
Kirstin R.W. Matthews, Monica M. MatsumotoOctober 6, 2014
Stem cells from umbilical cord blood (CB) can be used to treat over 80 different diseases, including many types of leukemia, lymphoma and inherited immune system disorders. Extensive storage facilities in the United States and around the world collect, test and freeze CB for later use in medical procedures. However, the divide between two different banking models — public versus private — presents policy challenges. This policy report examines the difference between public and private cord blood banks and offers recommendations for US policymakers to improve cord blood banking and ensure high quality standards.
Monica M. Matsumoto, Kirstin R.W. MatthewsOctober 6, 2014
A deadly virus named MERS has spread from Saudi Arabia to over a dozen countries since 2012. While the chances for widespread infection are remote due to the virus's low human-to-human transmission rate, all governments should nevertheless support academic freedom and scientific collaboration to keep local outbreaks of viruses like MERS from becoming serious pandemics.
Kirstin R.W. Matthews, Monica M. Matsumoto, Jon FlynnJuly 25, 2014
Peter Hotez, fellow in disease and poverty, proposes ways for countries around the world to increase their reliance on vaccine diplomacy in their foreign policy approaches.